JP2015501782A5 - - Google Patents

Download PDF

Info

Publication number
JP2015501782A5
JP2015501782A5 JP2014539984A JP2014539984A JP2015501782A5 JP 2015501782 A5 JP2015501782 A5 JP 2015501782A5 JP 2014539984 A JP2014539984 A JP 2014539984A JP 2014539984 A JP2014539984 A JP 2014539984A JP 2015501782 A5 JP2015501782 A5 JP 2015501782A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
heteroaryl
group
perfluoroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014539984A
Other languages
English (en)
Japanese (ja)
Other versions
JP6215832B2 (ja
JP2015501782A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/061597 external-priority patent/WO2013066684A1/en
Publication of JP2015501782A publication Critical patent/JP2015501782A/ja
Publication of JP2015501782A5 publication Critical patent/JP2015501782A5/ja
Application granted granted Critical
Publication of JP6215832B2 publication Critical patent/JP6215832B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014539984A 2011-11-04 2012-10-24 アミノピリミジンキナーゼ阻害剤 Expired - Fee Related JP6215832B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161555617P 2011-11-04 2011-11-04
US61/555,617 2011-11-04
PCT/US2012/061597 WO2013066684A1 (en) 2011-11-04 2012-10-24 Aminopyrimidine kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2015501782A JP2015501782A (ja) 2015-01-19
JP2015501782A5 true JP2015501782A5 (https=) 2015-12-17
JP6215832B2 JP6215832B2 (ja) 2017-10-18

Family

ID=47116510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539984A Expired - Fee Related JP6215832B2 (ja) 2011-11-04 2012-10-24 アミノピリミジンキナーゼ阻害剤

Country Status (14)

Country Link
US (3) US8927525B2 (https=)
EP (1) EP2776432B1 (https=)
JP (1) JP6215832B2 (https=)
KR (1) KR101990605B1 (https=)
CN (1) CN104011046B (https=)
AU (1) AU2012332931B2 (https=)
BR (1) BR112014010563B1 (https=)
CA (1) CA2853454C (https=)
ES (1) ES2629690T3 (https=)
IL (1) IL232234A0 (https=)
MX (1) MX347191B (https=)
PL (1) PL2776432T3 (https=)
RU (1) RU2674017C2 (https=)
WO (1) WO2013066684A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2516425T3 (pl) * 2009-12-23 2016-03-31 Jasco Pharmaceuticals Llc Inhibitory kinaz aminopirydynowych
EP2699569B1 (en) * 2011-04-22 2017-08-30 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
KR101990605B1 (ko) 2011-11-04 2019-06-18 자스코 파머수티컬스, 엘엘씨 아미노피리미딘 키나아제 억제제
ES2649156T3 (es) 2013-01-14 2018-01-10 Incyte Holdings Corporation Compuestos bicíclicos de carboxamida aromática útiles como inhibidores de quinasas Pim
PE20191245A1 (es) 2013-01-15 2019-09-18 Incyte Holdings Corp Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de quinasa pim
EA201690458A1 (ru) 2013-08-23 2016-07-29 Инсайт Корпорейшн Фуро- и тиенопиридинкарбоксамиды, используемые в качестве ингибиторов pim-киназы
US9822124B2 (en) 2014-07-14 2017-11-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
WO2016196244A1 (en) 2015-05-29 2016-12-08 Incyte Corporation Pyridineamine compounds useful as pim kinase inhibitors
US10376511B2 (en) * 2015-08-04 2019-08-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Pyrazole pyrimidine derivative and uses thereof
TWI734699B (zh) 2015-09-09 2021-08-01 美商英塞特公司 Pim激酶抑制劑之鹽
US9920032B2 (en) 2015-10-02 2018-03-20 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
MX394556B (es) 2017-02-01 2025-03-24 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Derivados de n1-(4-(5-(ciclopropilmetil)-1-metil-1h-pirazol-4-il) piridin-2-il) ciclohexano-1,4-diamina y compuestos relacionados como inhibidores de ck1 y/o irak1 para tratar cáncer.
WO2019113487A1 (en) 2017-12-08 2019-06-13 Incyte Corporation Low dose combination therapy for treatment of myeloproliferative neoplasms
UY38911A (es) 2019-10-09 2021-05-31 Bayer Ag Compuestos de heteroarilo-triazol como pesticidas, formulaciones, usos y métodos de uso de los mismos
WO2025132870A1 (en) * 2023-12-21 2025-06-26 Glaxosmithkline Intellectual Property (No.4) Limited Chemical compounds and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW245716B (https=) 1992-12-28 1995-04-21 Takeda Pharm Industry Co
US5955481A (en) 1994-03-28 1999-09-21 Nissan Chemical Industries, Ltd. Pyridine type thiazolidines
TW420669B (en) * 1994-03-28 2001-02-01 Nissan Chemical Ind Ltd Pyridine type thiazolidines
ATE238297T1 (de) 1994-10-20 2003-05-15 Nippon Chemiphar Co Chinolinderivat
KR20070027584A (ko) 2004-06-17 2007-03-09 와이어쓰 고나도트로핀 방출 호르몬 수용체 길항제
CN101052640B (zh) 2004-09-03 2011-05-11 默克雪兰诺有限公司 吡啶亚甲基唑烷酮类及其作为磷酸肌醇抑制剂的用途
ZA200702435B (en) 2004-10-12 2008-06-25 Serono Lab PI3 Kinase gamma inhibitors for the treatment of anaemia
EP1916249A1 (en) 2006-10-10 2008-04-30 LEK Pharmaceuticals D.D. 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
EP2217235A4 (en) * 2007-11-15 2011-01-12 Musc Found For Res Dev INHIBITORS OF PIM PROTEIN KINASES, COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
US8252823B2 (en) 2008-01-28 2012-08-28 New York University Oxazole and thiazole compounds as beta-catenin modulators and uses thereof
RU2011121655A (ru) 2008-10-29 2012-12-10 Сертрис Фармасьютикалз, Инк. Производные пиридина, бициклические производные пиридина и родственные аналоги в качестве модуляторов сиртуина
WO2010148351A1 (en) * 2009-06-18 2010-12-23 Cylene Pharmaceuticals, Inc. Rhodanines and related heterocycles as kinase inhibitors
PL2516425T3 (pl) 2009-12-23 2016-03-31 Jasco Pharmaceuticals Llc Inhibitory kinaz aminopirydynowych
EP2699569B1 (en) 2011-04-22 2017-08-30 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
KR101990605B1 (ko) 2011-11-04 2019-06-18 자스코 파머수티컬스, 엘엘씨 아미노피리미딘 키나아제 억제제

Similar Documents

Publication Publication Date Title
JP2015501782A5 (https=)
RU2014122344A (ru) Аминопиримидиновые ингибиторы киназ
JP2019516766A5 (https=)
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2019518766A5 (https=)
ME02452B (me) Sredstva za induciranje apoptoze namijenjena liječenju raka i imunih i autoimunih bolesti
JP2013535491A5 (https=)
JP2014520898A5 (https=)
RU2019142795A (ru) Производное n-(азаарил)циклолактам-1-карбоксамида, метод его получения и его применение
JP2013537203A5 (https=)
RU2018138828A (ru) Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами
JP2009263394A5 (https=)
JP2016513660A5 (https=)
JP2012153722A5 (https=)
JP2015531747A5 (https=)
JP2013502441A5 (https=)
CN106660974A (zh) 含氨磺酰基的1,2,5‑噁二唑类衍生物、其制备方法及其在医药上的应用
RU2019101220A (ru) Кристаллические формы соединения триазолопиримидина
RU2016143333A (ru) Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение
ME02838B (me) 3,4-dihidroizokinolin-2(1h)-ilni spojevi
JP2013509431A5 (https=)
JP2017502940A5 (https=)
JP2017508782A5 (https=)
JP2011502956A5 (https=)
RU2017104856A (ru) Функционализированные и замещенные индолы в качестве противораковых средств